“We’re preparing for 2021 today”: An update on the Therapeutics Accelerator
Trevor Mundel provides an update on the COVID-19 Therapeutics Accelerator's progress in research, manufacturing, and testing. Mundel leads the foundation's efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
A COVID-19 vaccine might be ready within 18 months. But what happens then?
Developing and manufacturing a vaccine against COVID-19 is only part of the solution. Coordination, political will, and the infrastructure to support equitable vaccine is distribution will be essential to the ongoing COVID-19 response.
Our COVID-19 response: Q&A with Mark Suzman
On Friday, April 17, Mark Suzman, CEO of the Gates Foundation, joined a conference call with The Optimist subscribers to discuss the foundation's response to the COVID-19 pandemic. Listen to the recording of the call here.
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.